|
⚲
|
| Keyboard |
| Calias Pericles
✚
|
|
|---|---|
| CIK # | 0001746282 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001746282] | |
| 4 | [0001746282] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Calias Pericles | |
| Avalo Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avalo Therapeutics Inc CERC
Common Stock
|
2019-12-10 | Buy | 2,913 | $2.85 | 8,302 |
|
Avalo Therapeutics Inc CERC
Common Stock
|
2019-07-16 | Tax withheld | 3,246 | $4.90 | 15,905 |
|
Avalo Therapeutics Inc CERC
Common Stock
|
2019-06-10 | Buy | 4,549 | $2.85 | 12,965 |
|
Avalo Therapeutics Inc CERC
Stock Option (Right to Buy) · derivative
|
2019-05-24 | Grant | 25,000 | $0.00 | |
|
Avalo Therapeutics Inc CERC
Common Stock
|
2019-05-24 | Grant | 45,000 | $0.00 | |
|
Avalo Therapeutics Inc CERC
Stock Option (Right to Buy) · derivative
|
2019-04-01 | Grant | 175,000 | $0.00 | |
|
Avalo Therapeutics Inc CERC
Stock Option (Right to Buy) · derivative
|
2018-07-16 | Grant | 80,000 | $0.00 |